ABALOPARATIDE

Abaloparatide 2 mg/mL injection, 1.5 mL pen device

ABALOPARATIDE (15436K)

Abaloparatide 2 mg/mL injection, 1.5 mL pen device
15436K
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe established osteoporosis
Treatment phase: Initial treatment - Second-line therapy

Restriction

Indication: Severe established osteoporosis
Treatment phase: Continuing treatment - Second-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $387.19 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Eladynos